Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-blind, Placebo-controlled Phase II Trial (MAyflOwer RoAD)
Manuscript Number:
16-1309R1
Author(s):
Mercè Boada, Edilio Borroni, Tracie Carey, Christian Czech, Paul Delmar, Rachelle S. Doody, Juergen Dukart, Paulo Fontoura, Irene Gerlach, Inma Gilaberte, Timo Grimmer, Marie Mannino, Nicoletta Milani Muelhardt, Emma Moran, Stephane Nave, Tania Nikolcheva, Susanne Ostrowitzki, Meike Pauly-Evers, Benedicte Ricci, Luca Santarelli, Juha-Matti Savola
Disclosures
Mercè Boada
Consulting Fees:
Dr. M. Boada has consulted for Araclon, Avid, Bayer, Elan, Grifols, Janssen/Pfizer, Lilly, MSD, Nutricia, Roche, Sanofi, and Servier.
Lecture Fees:
She received fees for lectures and funds for research from Araclon, Grifols, Merck, Novartis, Nutricia, Piramal, Roche, and Servier.
Grants
Agency:
EFSD - European Foundation for the Study of Diabetes. EFSD/Lilly Mental Health and Diabetes Programme.
Dates:
2014-2015
Edilio Borroni
Sponsors:
I am a full time employee of Hoffmann-La Roche Ltd. I am currently working in the CNS Biomarker group.
Tracie Carey
Equity:
As an employee of Roche, I am awarded stock options and stock as part of a long-term incentives plan. Currently I hold 79 shares and stock options which are worth a little over $12,000 US as of April 20,2017. I have other options and stock units in my account which are not yet vested.
I hold about 100 shares of Teva Pharmaceuticals stock.
Sponsors:
I am a full-time employee of Roche located at the Roche Innovation Center, New York, USA
Christian Czech
Equity:
Member of the Roche employees stock program
Sponsors:
Full time employee of Roche
Paul Delmar
Equity:
F. Hoffmann - La Roche Ltd.
Sponsors:
Full Time Employee - F. Hoffmann-La Roche Ltd.
Rachelle S. Doody
Equity:
Stock options in Roche and AZ Therapies
Sponsors:
At the time of the study, I was working at Baylor College of Medicine, but am now employed by Roche
Juergen Dukart
Sponsors:
regular employee
Paulo Fontoura
Equity:
Stock ownership in F Hoffmann-La Roche
Sponsors:
Current employee of F Hoffmann-La Roche
Irene Gerlach
Equity:
less than 500 shares in Novartis
les than 500 shares and stock options in Roche (study sponsor)
Sponsors:
Project Leader in Neuroscience Development
Inma Gilaberte
Sponsors:
I was clinical director at the time the study was finalized
Timo Grimmer
Consulting Fees:
Consulting fees from Actelion, Eli Lilly, MSD; Novartis, Quintiles, Roche Pharma
Lecture Fees:
Lecture fees from Biogen, Lilly, Parexel, Roche Pharma
Marie Mannino
Equity:
I own Roche stock
Sponsors:
I work for Roche Pharmaceuticals, the sponsor of the study.